Search

everythinglearnresearchcommunity

for

Search:↓

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Tofacitinib treatment is used for teenagers with alopecia areata.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Upadacitinib effectively treats psoriasis and lichen planus together.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Deucravacitinib helped a man regrow hair significantly.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

The root extract of Untica mairei Levl may help treat benign prostatic hyperplasia.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

New hybrid compound found to effectively prevent hair loss.

Some herbs show promise as antiandrogenic agents.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Teriflunomide can cause hair thinning.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Combining different treatments may be needed to effectively manage chronic prostatitis.